There are 807 resources available
Strategies of molecular identification of the tissue of origin: Perceived value and ongoing research
Presenter: Linda Mileshkin
Session: Cancer of Unknown Primary: Investigating the primary and the biology (In collaboration with National Societies)
Resources:
Slides
Webcast
Targeting key oncodrivers in CUP
Presenter: Michelle Wilson
Session: Cancer of Unknown Primary: Investigating the primary and the biology (In collaboration with National Societies)
Resources:
Slides
Webcast
The search for a CUP: Specific molecular signature
Presenter: Valerie Yang
Session: Cancer of Unknown Primary: Investigating the primary and the biology (In collaboration with National Societies)
Resources:
Slides
Webcast
Managing patients with CUP: The ESMO Clinical Practice guidelines
Presenter: Alwin Krämer
Session: Cancer of Unknown Primary: Investigating the primary and the biology (In collaboration with National Societies)
Resources:
Slides
Webcast
Tumour-agnostic precision therapeutics: The concept and key successes in clinical practice
Presenter: Takayuki Yoshino
Session: Tumour-agnostic precision therapeutics: What is the way forward? (In collaboration with National Societies)
Resources:
Slides
Webcast
Implementing NGS multiplex testing for actionable biomarkers in solid tumours
Presenter: Hsiang-Fong Kao
Session: Tumour-agnostic precision therapeutics: What is the way forward? (In collaboration with National Societies)
Resources:
Slides
Webcast
Challenges in the development of tumour-agnostic targeted agents
Presenter: Kan Yonemori
Session: Tumour-agnostic precision therapeutics: What is the way forward? (In collaboration with National Societies)
Resources:
Slides
Webcast
Tumour-agnostic therapies: Considerations on generation of evidence frameworks
Presenter: Christoph Benedikt Westphalen
Session: Tumour-agnostic precision therapeutics: What is the way forward? (In collaboration with National Societies)
Resources:
Slides
Webcast
Academic research contributions in oncology drug development
Presenter: Ruihua Xu
Session: Optimising development and uptake of precision oncology in the Far East (In collaboration with National Societies)
Resources:
Slides
Webcast
The development and implementation of biosimilars in the era of personalized cancer medicine
Presenter: Dennis Sacdalan
Session: Optimising development and uptake of precision oncology in the Far East (In collaboration with National Societies)
Resources:
Slides
Webcast